Press Releases

Press Releases

Discovery Laboratories, Inc., a biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, today announced that it has initiated its AEROSURF® phase 2b clinical trial in premature infants 26 to 32 weeks gestational age (GA) receiving non-invasive nasal continuous positive airway pressure (nCPAP) for respiratory distress syndrome…

Press Releases

Perrigo Company plc today announced that Perrigo Chairman and CEO Joseph Papa will present at the 34th Annual J.P. Morgan Healthcare Conference at 8:00 AM PST on Monday, January 11, 2016 at the Westin St. Francis Hotel in San Francisco, California. Interested parties can access the presentation webcast at http://perrigo.investorroom.com/events-webcasts.…

Press Releases

Teikoku Pharma USA, Inc. announced today that the U.S. Food and Drug Administration ("FDA") has approved Docetaxel Injection, Non-Alcohol Formula ("Docetaxel Injection") for the treatment of breast cancer, non-small cell lung cancer, prostate cancer, gastric adenocarcinoma, and head and neck cancer.  Teikoku entered into an exclusive licensing agreement with Eagle…

Press Releases

Epizyme, Inc., a clinical stage biopharmaceutical company creating novel epigenetic therapies for cancer patients, today announced the U.S. Food and Drug Administration’s (FDA) Division of Hematology Products has accepted the company’s investigational new drug (IND) application for tazemetostat for the treatment of adults with diffuse large B-cell lymphoma (DLBCL), the…

Press Releases

With deep sadness, Regeneron Pharmaceuticals, Inc. today announced the passing of Alfred Gilman, M.D., Ph.D. Dr. Gilman was a co-founder of Regeneron and had been a Director since July 1990. His life-long passion for science greatly advanced medical knowledge and won him much recognition, including the Nobel Prize in Physiology…

Press Releases

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the intended treatment of acute pain, reported that the Committee for Medicinal Products for Human Use (CHMP) at the European Medicines Agency (EMA) has confirmed that a Marketing Authorization Application (MAA) for ARX-04…

Press Releases

ANI Pharmaceuticals, Inc. today announced the commercial launch of Nimodipine 30mg Capsules, a product developed by collaboration partner Sofgen. The overall US market for Nimodipine is $25 million, per IMS Health. Arthur S. Przybyl, President and Chief Executive Officer said, "We are pleased to announce the launch of Nimodipine, the…

Press Releases

Merrimack Pharmaceuticals, Inc. today announced it filed an amendment to its ongoing Phase 2 clinical study of MM-121 (seribantumab) in patients with heregulin-positive non-small cell lung cancer (NSCLC) with the U.S. Food and Drug Administration (FDA). The amendment includes a change in primary endpoint to overall survival to enable a…

Press Releases

Novoron Bioscience, Inc., a private biotech company dedicated to developing new therapeutics for disorders of the central nervous system, today announced that the company has been awarded a National Institutes of Health (NIH) grant under the Small Business Innovation Research (SBIR) Program.  The NIH grant totaling $680,000 will fund preclinical…

Press Releases

Merrimack Pharmaceuticals, Inc. announced today the closing of a private placement of $175 million in aggregate principal amount of its senior secured notes due 2022 (the "Notes"). The Notes were sold only to qualified institutional buyers within the meaning of Rule 144A under the Securities Act of 1933, as amended…